Category: Otolaryngology & Head and Neck Surgery
Lump Beside the Ear / Enlarged Parotid — Do You Need Surgery? Decoding Cancer Risk and Facial-Nerve–Safe Techniques
Most parotid gland tumors — roughly 80% — are benign masses such as pleomorphic adenoma, not cancer. Even so, surgeons often recommend removal because benign tumors can transform into malignancy if left for years, and a growing mass compresses the facial nerve (CN VII), making surgery harder. Evaluation and surgery should be with an otolaryngologist (ENT) or head and neck surgeon.
1. Understanding the Parotid Gland and Why Lumps Form
The parotid gland is the largest salivary gland, located beside the cheek and below the earlobe.
It produces saliva that enters the mouth. Most palpable masses here arise from salivary gland neoplasms
(not always an “abscess” or lymph node). Even a painless, firm lump deserves proper workup.
The exact cause of each tumor type is not always single-factor.
Smoking is linked to Warthin tumor in some reports,
and certain masses grow slowly over years — leading many people to delay care
(NCBI — salivary gland neoplasms).
2. Tumor Types: ~80% Benign vs ~20% Malignant
In the parotid gland overall, about 80% of tumors are non-cancerous and about 20% are malignant
— population-level estimates from clinical literature, not an individual diagnosis
(NCI PDQ — salivary gland).
- Common benign types: pleomorphic adenoma, Warthin tumor
- Common malignant types in this group: mucoepidermoid carcinoma, adenoid cystic carcinoma, and others
Table 1: Benign vs Malignant Parotid Gland Tumors
| Mass characteristics | Approximate frequency | Growth rate | Associated symptoms (pain/weakness) | Treatment approach |
|---|---|---|---|---|
| Benign (e.g., pleomorphic adenoma) | ~80% of parotid masses | Usually slow — months to years | Often painless; no facial weakness early on | Surgical removal + pathology confirmation; surveillance if surgery deferred |
| Malignant (salivary gland cancer) | ~20% | Often faster / clearly changing | May have pain, fixation, facial weakness, enlarged lymph nodes | Surgery ± radiation/systemic therapy by type and stage — specialist team |
3. Why Remove a “Benign” Mass? Malignant Transformation Risk (Carcinoma ex Pleomorphic Adenoma)
Pleomorphic adenoma left for many years can transform into
carcinoma ex pleomorphic adenoma.
Risk rises with longer duration and larger size
(PubMed — CXPA).
Another key reason is the facial nerve (CN VII)
running through the parotid gland. As the mass grows,
it compresses the nerve — making late surgery harder and increasing facial weakness risk compared with operating when the tumor is still small.
4. Diagnostic Steps: Ultrasound, Fine Needle Aspiration (FNA), and MRI/CT Scan
When you find a lump beside the ear or below the earlobe, see an otolaryngologist (ENT)
or head and neck surgeon directly. Common steps include:
- Ultrasound: assesses mass characteristics, margins, and nearby lymph nodes
- Fine needle aspiration (FNA): a small needle samples cells for pathology — minimal discomfort, similar to an injection; helps estimate benign vs malignant tendency before surgery
- CT or MRI: surgical planning, nerve relationship, and deep structure assessment — especially for large or suspicious masses
FNA does not always replace whole-tumor pathology after surgery — final diagnosis is confirmed postoperatively.
Rapid growth, pain, or facial weakness — do not ignore warning signs
Analyze severity and receive personalized guidance from our Advisory team.
5. Parotidectomy Techniques and Facial Nerve Preservation
Modern parotid surgery emphasizes
careful identification and dissection of the facial nerve before removing tumor tissue.
Some centers use intraoperative nerve monitoring.
Incisions are often placed along the ear crease and behind the ear to reduce visible scarring.
Table 2: Parotidectomy Surgical Options & Facial Nerve Safety
| Surgery type | Tissue extent | Facial nerve (CN VII) risk level | Recovery time (approximate) |
|---|---|---|---|
| Superficial / partial parotidectomy | Removes superficial gland containing the mass + safe margin | Low–moderate if nerve is clearly identified (temporary weakness possible) | Often home within days; swelling and wound improve over weeks |
| Total parotidectomy | Removes nearly entire gland / deep tumor component | Higher than partial — longer nerve dissection required | Longer; may need drains and close facial follow-up |
| Radical (invasive cancer) | May include adjacent structures per disease extent | Highest — nerve sacrifice sometimes required if invaded by cancer | Depends on extent and combined radiation/systemic plans |
6. After Surgery: Care and What to Watch For
- Follow wound care instructions; watch for sudden bleeding or swelling at the neck or cheek
- Monitor eye closure, eyebrow raise, and smile — contact the surgical team if weakness worsens after discharge
- Some patients develop sweating while chewing (Frey syndrome) long term — report at follow-up
- Wait for final pathology after surgery to confirm tumor type and surveillance plan
Red Flags — Seek Care Promptly / Emergency
- Clearly rapid growth over weeks to a few months
- Severe pain, fixation to skin, or ulceration/bleeding
- Facial weakness, incomplete eye closure, one-sided drooling
- Enlarged neck lymph nodes, or difficulty swallowing/breathing with the mass
- After surgery: rapid swelling, heavy oozing, breathing difficulty — emergency services
Frequently Asked Questions (FAQ)
How likely is a parotid gland tumor to become cancer?
Overall, about 80% are benign — such as pleomorphic adenoma and Warthin tumor —
while roughly 20% are primary malignancies. For benign pleomorphic adenoma,
leaving the mass for many years carries a risk of transformation into carcinoma ex pleomorphic adenoma,
with higher rates when the tumor has been present longer and grows larger — individual assessment with a specialist is essential.
Why do doctors recommend surgery even when initial tests are not cancer?
Because (1) malignant transformation risk when a tumor is left for years, and (2) a growing mass compresses the facial nerve,
making surgery harder and increasing facial weakness risk compared with operating when the tumor is still small.
Does parotid surgery risk the facial nerve, and how do surgeons protect it?
There is risk because the nerve traverses the gland. Surgeons carefully identify and dissect the nerve;
some use intraoperative monitoring. The goal is to preserve eyebrow raise, eye closure, and smile as close to preoperative function as possible.
Which specialist should I see for a hard lump beside the ear, earlobe, or under the jaw?
See an otolaryngologist (ENT) or head and neck surgeon directly
for ultrasound/CT/MRI and FNA before planning surgery.
What signs mean I should seek care sooner?
Rapid growth, severe pain, fixation, facial weakness, enlarged neck lymph nodes, or ulceration/bleeding from the mass
— seek ENT or head and neck care promptly.
Clinical Mechanism: Why “Operating While Small” Is Safer Long Term
The facial nerve branches within parotid tissue.
An expanding mass changes the surgical plane and increases nerve injury risk.
Pleomorphic adenoma can accumulate malignant potential over time —
which is why most guidelines support surgery for suspected salivary neoplasms
even when population-level data suggest benign disease. Synthesized by
Asst. Prof. Dr. Norawit Raatpiboon,
citing
CXPA literature
and
NCI salivary gland PDQ.
References and E-E-A-T
- NCI — Salivary Gland Cancer Treatment (PDQ®)
- PubMed — Carcinoma ex pleomorphic adenoma (2006 review context)
- NCBI Bookshelf — Salivary Gland Tumors
Read more:
Cancer Care Urgency Score
·
ENT hub
·
Oncology hub
Medical Disclaimer
This page provides general education about parotid gland tumors. It is not a personal diagnosis or surgical plan.
Evaluation and treatment decisions require an otolaryngologist or head and neck surgeon caring for you,
plus actual test results (FNA, imaging, pathology). For emergencies, contact emergency services immediately.